Shuaishuai Zhang
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Identification of a CAR-Derived Clone by NGS-Based MRD After Fully Human BCMA CAR T-Cell Therapy in Multiple Myeloma.
Journal: American journal of hematology
Published: April 24, 2025
The specific transcriptional profile and clonal selection of monoclonal gammopathy of undetermined significancelike behavior predict an exceptionally favorable prognosis in multiple myeloma.
Journal: Haematologica
Published: February 06, 2025
Uncommon biphasic CAR-T expansion induces hemophagocytic lymphohistiocytosis-like syndrome and fatal multiple infections following BCMA CAR-T cell therapy: a case report.
Journal: Journal for immunotherapy of cancer
Published: November 08, 2024
The Monoclonal Gammopathy of Undetermined Significance-Like (MGUS-like) Classifier Stratifies Prognosis in Multiple Myeloma: Results from Real-World Data in Chinese Population.
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 22, 2024
Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 21, 2024
Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM).
Journal: Annals of hematology
Published: October 12, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026